Cargando…

An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion

In the first part of this Review, we presented case-series where Kampo treatment was introduced for those atopic dermatitis (AD) patients who had failed with conventional therapy, in an attempt to prove that there exists a definite subgroup of AD patients for whom Kampo treatment is effective. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Hiromi, Takahashi, Kuniaki, Mizuno, Nobuyuki, Kutsuna, Haruo, Ishii, Masamitsu
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516458/
https://www.ncbi.nlm.nih.gov/pubmed/15480440
http://dx.doi.org/10.1093/ecam/neh026
_version_ 1782121767356071936
author Kobayashi, Hiromi
Takahashi, Kuniaki
Mizuno, Nobuyuki
Kutsuna, Haruo
Ishii, Masamitsu
author_facet Kobayashi, Hiromi
Takahashi, Kuniaki
Mizuno, Nobuyuki
Kutsuna, Haruo
Ishii, Masamitsu
author_sort Kobayashi, Hiromi
collection PubMed
description In the first part of this Review, we presented case-series where Kampo treatment was introduced for those atopic dermatitis (AD) patients who had failed with conventional therapy, in an attempt to prove that there exists a definite subgroup of AD patients for whom Kampo treatment is effective. In this second part, we will first provide the summary of the results for 140 AD patients we treated in 2000. The results suggest that Kampo treatment is effective for more than half of AD patients who fail with conventional therapy. In the Discussion, we will examine the evidential basis for conventional AD therapy and discuss how Kampo treatment should be integrated into the guidelines for AD therapy. We contend that Kampo treatment should be tried before systematic immunosuppressive agents are considered. As each Kampo treatment is highly individualized, it should be regarded more as ‘art’ than technology, and special care should be taken to assess its efficacy in clinical trial.
format Text
id pubmed-516458
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-5164582004-10-08 An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion Kobayashi, Hiromi Takahashi, Kuniaki Mizuno, Nobuyuki Kutsuna, Haruo Ishii, Masamitsu Evid Based Complement Alternat Med Review In the first part of this Review, we presented case-series where Kampo treatment was introduced for those atopic dermatitis (AD) patients who had failed with conventional therapy, in an attempt to prove that there exists a definite subgroup of AD patients for whom Kampo treatment is effective. In this second part, we will first provide the summary of the results for 140 AD patients we treated in 2000. The results suggest that Kampo treatment is effective for more than half of AD patients who fail with conventional therapy. In the Discussion, we will examine the evidential basis for conventional AD therapy and discuss how Kampo treatment should be integrated into the guidelines for AD therapy. We contend that Kampo treatment should be tried before systematic immunosuppressive agents are considered. As each Kampo treatment is highly individualized, it should be regarded more as ‘art’ than technology, and special care should be taken to assess its efficacy in clinical trial. Oxford University Press 2004-09 /pmc/articles/PMC516458/ /pubmed/15480440 http://dx.doi.org/10.1093/ecam/neh026 Text en © 2004, the authors Evidenced-based Complementary and Alternative Medicine, Vol. 1, Issue 2 © Oxford University Press 2004; all rights reserved. The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.
spellingShingle Review
Kobayashi, Hiromi
Takahashi, Kuniaki
Mizuno, Nobuyuki
Kutsuna, Haruo
Ishii, Masamitsu
An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title_full An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title_fullStr An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title_full_unstemmed An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title_short An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion
title_sort alternative approach to atopic dermatitis: part ii—summary of cases and discussion
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516458/
https://www.ncbi.nlm.nih.gov/pubmed/15480440
http://dx.doi.org/10.1093/ecam/neh026
work_keys_str_mv AT kobayashihiromi analternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT takahashikuniaki analternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT mizunonobuyuki analternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT kutsunaharuo analternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT ishiimasamitsu analternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT kobayashihiromi alternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT takahashikuniaki alternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT mizunonobuyuki alternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT kutsunaharuo alternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion
AT ishiimasamitsu alternativeapproachtoatopicdermatitispartiisummaryofcasesanddiscussion